IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q3 2020 Holdings

Filed 2020-11-12 | 6 holdings | $96.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$32.1K1,615,32133.2%
Surface Oncology IncCOM86877M209$32.1K4,645,45333.2%
Spero Therapeutics Inc(SPRO)COM84833T103$15.4K1,376,96815.9%
Unum Therapeutics IncCOM903214104$7.9K3,361,5358.1%
Synlogic IncCOM87166L100$5.4K2,651,9635.5%
Snap Inc(SNAP)CL A83304A106$3.9K150,1604.1%